Process Optimization

The Hidden Cost of How Chemical Companies Experiment

Smart Experimentation - why the combination of Design of Experiments and Bayesian Optimization with intuitive analytics is the most important productivity lever your R&D organization isn't using

News • Bioprocessing

Lilly Announces New $4.5 Billion Site

Eli Lilly and Company (Lilly) recently announced a $4.5 billion (€4.07 billion) investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.

Sponsored • Whitepaper • Bioprocessing

E. Coli Bioprocessing: Pioneering Advances in Biotechnology

Download this complimentary Expert Insights eBook today!

Whitepaper • Technology

Advance with Intelligence

By fully realizing the potential of data-driven analysis and machine learning, chemical producers can maximize plant uptime and optimize process efficiency.

News

Ypso-Facto anticipates a solid growth in 2016

Topics • Technology

How to Achieve Sustainable Business?

Top-Feature

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

CHEManager International c/o Wiley-VCH GmbH

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.